Invesco Nasdaq Biotechnology Etf Performance

IBBQ Etf  USD 21.73  0.05  0.23%   
The etf retains a Market Volatility (i.e., Beta) of 0.22, which attests to not very significant fluctuations relative to the market. As returns on the market increase, Invesco Nasdaq's returns are expected to increase less than the market. However, during the bear market, the loss of holding Invesco Nasdaq is expected to be smaller as well.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Invesco Nasdaq Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Etf's fundamental drivers remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the ETF retail investors. ...more
1
Proactive Strategies - Stock Traders Daily
11/12/2024
2
Short Interest in Invesco Nasdaq Biotechnology ETF Declines By 20.0
12/16/2024
In Threey Sharp Ratio-0.28
  

Invesco Nasdaq Relative Risk vs. Return Landscape

If you would invest  2,333  in Invesco Nasdaq Biotechnology on October 9, 2024 and sell it today you would lose (160.00) from holding Invesco Nasdaq Biotechnology or give up 6.86% of portfolio value over 90 days. Invesco Nasdaq Biotechnology is currently does not generate positive expected returns and assumes 1.2247% risk (volatility on return distribution) over the 90 days horizon. In different words, 10% of etfs are less volatile than Invesco, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Invesco Nasdaq is expected to under-perform the market. In addition to that, the company is 1.51 times more volatile than its market benchmark. It trades about -0.09 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.01 per unit of volatility.

Invesco Nasdaq Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Invesco Nasdaq's investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as Invesco Nasdaq Biotechnology, and traders can use it to determine the average amount a Invesco Nasdaq's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.089

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsIBBQ

Estimated Market Risk

 1.22
  actual daily
10
90% of assets are more volatile

Expected Return

 -0.11
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.09
  actual daily
0
Most of other assets perform better
Based on monthly moving average Invesco Nasdaq is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Invesco Nasdaq by adding Invesco Nasdaq to a well-diversified portfolio.

Invesco Nasdaq Fundamentals Growth

Invesco Etf prices reflect investors' perceptions of the future prospects and financial health of Invesco Nasdaq, and Invesco Nasdaq fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Invesco Etf performance.

About Invesco Nasdaq Performance

Assessing Invesco Nasdaq's fundamental ratios provides investors with valuable insights into Invesco Nasdaq's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Invesco Nasdaq is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
The fund generally will invest at least 90 percent of its total assets in the securities that comprise the index. Invesco Nasdaq is traded on NASDAQ Exchange in the United States.
Invesco Nasdaq Biote generated a negative expected return over the last 90 days
Latest headline from thelincolnianonline.com: Short Interest in Invesco Nasdaq Biotechnology ETF Declines By 20.0
The fund created three year return of -2.0%
Invesco Nasdaq Biote retains 99.97% of its assets under management (AUM) in equities
When determining whether Invesco Nasdaq Biote is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Invesco Etf is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Invesco Nasdaq Biotechnology Etf. Highlighted below are key reports to facilitate an investment decision about Invesco Nasdaq Biotechnology Etf:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Invesco Nasdaq Biotechnology. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
The market value of Invesco Nasdaq Biote is measured differently than its book value, which is the value of Invesco that is recorded on the company's balance sheet. Investors also form their own opinion of Invesco Nasdaq's value that differs from its market value or its book value, called intrinsic value, which is Invesco Nasdaq's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Invesco Nasdaq's market value can be influenced by many factors that don't directly affect Invesco Nasdaq's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Invesco Nasdaq's value and its price as these two are different measures arrived at by different means. Investors typically determine if Invesco Nasdaq is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Invesco Nasdaq's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.